IGF2BP3 and liver cancer: Lu et al. confirmed that IGF2BP3 inhibits ferroptosis in liver cancer cells by promoting the stability of NRF2 mRNA in an m6A-dependent manner, resulting in a reduced therapeutic effect of sorafenib on nude mice.